Trademark: 88048416
Word
ACCELERATING INNOVATION IN NK CELL THERAPY
Status Date
Monday, July 11, 2022
Filing Date
Monday, July 23, 2018
Published for Opposition
Tuesday, April 9, 2019
Abandoned Date
Monday, July 11, 2022
5 Pharmaceutical preparations for the treatment of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use; biological preparations for the treatment of cancer; therapeutic pharmaceuticals utilizing neural crest cells for use in the treatment of cancer, autoimmune disease and infectious diseases; Cell preparations, cellular vaccines and cellular biologics for the treatment of cancer and infectious diseases by autologous cell-based immunotherapy
44 Medical testing for diagnostic or treatment purposes in the field of cancer research; medical diagnostic testing, monitoring and reporting services; medical evaluation of immuno oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; medical monitoring services; medical diagnostic, prognostic and theranostic screening and testing services; collection and preservation of dna for medical purposes; consulting services in the nature of providing medical information; consulting services in the field of healthcare and cancer diagnoses; providing a website featuring health and healthcare information related to cancer, testing and screening; genetic testing for medical purposes; providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; providing genetics assessments in the nature of genetic counseling; genetic testing for medical diagnostic purposes; genomic testing for medical diagnostic purposes; Gene analysis and sequencing and DNA analysis and sequencing for medical diagnostic purposes and veterinary diagnostics purposes; gene analysis and sequencing and DNA analysis and sequencing for use in cancer diagnosis and treatment; providing a website featuring health and healthcare information related to cancer research
42 Scientific and technological services, namely, scientific research, design, analysis and testing in the field of cancer evolution and new cancer therapies using natural killer cells; industrial research in the field of new pharmaceutical products and new cancer therapies; medical and veterinary research services in the nature of the manipulation of cells within a laboratory or research facility to enable natural killer cells to be used for medical or therapeutic purposes; scientific research in the development of new cancer therapies; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services; Conducting research and clinical trials for others relating to the use and the engineering of natural killer cells and cancer treatment and therapy; medical and scientific research in the field of cancer treatment and diagnosis; data collection for others for research purposes, namely, the collection, testing and research of patient molecular and genomic data; collection and preservation of human and animal DNA for research purposes
Jul 11, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 11, 2022
Abandonment - No Use Statement Filed
Dec 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2021
Sou Extension 5 Granted
Nov 22, 2021
Sou Extension 5 Filed
Nov 30, 2021
Case Assigned To Intent To Use Paralegal
Nov 22, 2021
Sou Teas Extension Received
Nov 17, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 17, 2021
Teas Change Of Correspondence Received
Nov 17, 2021
Teas Change Of Domestic Representatives Address
Nov 17, 2021
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 17, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 17, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 17, 2021
Teas Change Of Owner Address Received
May 20, 2021
Notice Of Approval Of Extension Request E-Mailed
May 18, 2021
Sou Extension 4 Granted
May 18, 2021
Sou Extension 4 Filed
May 18, 2021
Sou Teas Extension Received
Dec 23, 2020
Automatic Update Of Assignment Of Ownership
Dec 5, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 3, 2020
Sou Extension 3 Granted
Dec 3, 2020
Sou Extension 3 Filed
Dec 3, 2020
Sou Teas Extension Received
Jun 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 2, 2020
Sou Extension 2 Granted
Jun 2, 2020
Sou Extension 2 Filed
Jun 2, 2020
Sou Teas Extension Received
Dec 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 4, 2019
Sou Extension 1 Granted
Dec 4, 2019
Sou Extension 1 Filed
Dec 4, 2019
Sou Teas Extension Received
Jun 4, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 9, 2019
Official Gazette Publication Confirmation E-Mailed
Apr 9, 2019
Published For Opposition
Mar 20, 2019
Notification Of Notice Of Publication E-Mailed
Mar 5, 2019
Approved For Pub - Principal Register
Mar 5, 2019
Examiner's Amendment Entered
Mar 5, 2019
Notification Of Examiners Amendment E-Mailed
Mar 5, 2019
Examiners Amendment E-Mailed
Mar 5, 2019
Examiners Amendment -Written
Mar 4, 2019
Previous Allowance Count Withdrawn
Feb 26, 2019
Withdrawn From Pub - Og Review Query
Feb 13, 2019
Law Office Publication Review Completed
Feb 11, 2019
Assigned To Lie
Jan 28, 2019
Approved For Pub - Principal Register
Jan 23, 2019
Teas/Email Correspondence Entered
Jan 22, 2019
Correspondence Received In Law Office
Jan 22, 2019
Teas Response To Office Action Received
Nov 20, 2018
Notification Of Non-Final Action E-Mailed
Nov 20, 2018
Non-Final Action E-Mailed
Nov 20, 2018
Non-Final Action Written
Nov 8, 2018
Assigned To Examiner
Jul 26, 2018
New Application Office Supplied Data Entered
Jul 26, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
